Author

Angelo Raggioli

European Molecular Biology LaboratoryORCID 0000-0002-6748-0307Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Neuroscience· 2 Cancer Biology· 1 Immunology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 5 Research Focus:drug response / drug discovery· 2 Assay:imaging· 2 Organism:mouse· 2 Research Focus:benchmarking· 1 Research Focus:cell-cell communication· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

Stefano Colloca· 3 shared Antonella FolgoriiD· 2 shared Cornelius Thilo GrossiD· 2 shared Stefania CaponeiD· 2 shared Adriano Leuzzi· 1 shared Adrianus C. M. BooniD· 1 shared Alan DodsoniD· 1 shared Alessandra VitelliiD· 1 shared

Activity by Year

2018-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

Stefano Colloca

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

Cancer BiologybioRxivPreprintMar 1, 2026

A novel Gorilla-derived oncolytic Adenovirus with natural selective replication in cancer cells

Romina Scala, Ilaria Cela, Emily Capone…·Angelo Raggioli

This paper develops a novel gorilla-derived oncolytic adenovirus, GRAd32Fk25, which selectively replicates in tumor cells and expresses a therapeutic antibody, showing potential as an improved virotherapy compared to HAd5.

DOI 10.64898/2026.02.26.708271

experimental assaydrug response / drug discovery

𝕏 PostBluesky

Pharmacology & ToxicologyVaccinesPeer-reviewedFeb 6, 2026

Non-clinical safety of GRAd vector-based COVID-19 and HIV vaccines supports a platform regulatory approach

Reji Paalangara, Stéphanie Gohin, Alexis Menard…·Stefania Capone

This study evaluates the non-clinical safety of two GRAd vector-based vaccines for COVID-19 and HIV, showing consistent safety profiles and supporting a regulatory platform approach.

2 citationstop 4%

rathuman

𝕏 PostBluesky

ImmunologybioRxivPreprintNov 22, 2023

Durable immunity to SARS-CoV-2 in both lower and upper airways achieved with a gorilla adenovirus (GRAd) S-2P vaccine in non-human primates

Juan I. Moliva, Shayne F. Andrew, Barbara J. Flynn…·Nancy J. Sullivan

This study shows a gorilla adenovirus-based vaccine provides durable immunity against SARS-CoV-2 in both airways of non-human primates, with enhanced protection from aerosol delivery and prime-boost regimens.

5 citations

non-human primateproteomics

𝕏 PostBluesky

NeuroscienceMammalian GenomePeer-reviewedOct 30, 2019

Mouse model of the human serotonin transporter-linked polymorphic region

Łukasz Piszczek, Simone Memoli, Angelo Raggioli…·Cornelius Thilo Gross

The paper develops a mouse model of the human 5-HTT-LPR polymorphism to study its effects on gene expression, serotonin homeostasis, and behavioral traits.

1 citation

mouseexperimental assay

𝕏 PostBluesky

NeuroscienceNature CommunicationsPeer-reviewedMar 26, 2018

Microglia remodel synapses by presynaptic trogocytosis and spine head filopodia induction

Laetitia Weinhard, Giulia Di Bartolomei, Giulia Bolasco…·Cornelius Thilo Gross

This study identifies microglia-mediated synaptic remodeling through trogocytosis and filopodia induction in developing hippocampal cultures.

787 citationstop 1%

mouseimaging

𝕏 PostBluesky